ID: ALA5182739

Max Phase: Preclinical

Molecular Formula: C18H31N5O5

Molecular Weight: 397.48

Associated Items:

Representations

Canonical SMILES:  Cn1oc(=O)n(CCCCCCCCCCCCn2c(=O)on(C)c2=O)c1=N

Standard InChI:  InChI=1S/C18H31N5O5/c1-20-15(19)22(17(25)27-20)13-11-9-7-5-3-4-6-8-10-12-14-23-16(24)21(2)28-18(23)26/h19H,3-14H2,1-2H3

Standard InChI Key:  LPEVEQZXCPSNIH-UHFFFAOYSA-N

Associated Targets(non-human)

Plasmodium vinckei petteri 380 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 397.48Molecular Weight (Monoisotopic): 397.2325AlogP: 1.31#Rotatable Bonds: 13
Polar Surface Area: 121.06Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.05CX LogP: 3.79CX LogD: 3.79
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: -0.31

References

1. Kim SH, Semenya D, Castagnolo D..  (2021)  Antimicrobial drugs bearing guanidine moieties: A review.,  216  [PMID:33640673] [10.1016/j.ejmech.2021.113293]

Source